Jennifer Crombie, MD, Dana-Farber Cancer Institute, Boston, Massachusetts, discusses results from a real-world study of lisocabtagene maraleucel in patients with relapsed/refractory large B-cell lymphoma. Similar to published findings…
Tanya Siddiqi, MD, medical director of lymphoma, City of Hope, Orange County, California, discusses the primary analysis of the TRANSCEND CLL 004 trial. This phase 1/2, single-arm, multicenter…
Les Edrich, MD, a general surgeon from Long Beach, California, discusses the concept of a two-tiered medical system and whether it would have an impact on quality of…
Les Edrich, MD, a general surgeon from Long Beach, California, provides an interesting look at reimbursement with the Medicaid program. Sponsored by The Doctor’s Channel
General Surgeon, Les Edrich, MD discusses an alternative to Veress needle entry during laparoscopic cholecystectomy that may help avoid injury to the intrabdominal organs and the potential resulting…
Mepolizumab, an IL-5 inhibitor, failed to alleviate moderate persistent asthma symptoms in a phase II trial of patients resistant to corticosteroids. References and Resources Flood-Page P, Swenson C,…
This study shows that compared with activation in the MTL, deactivation in the PMCs could be a more sensitive marker of early AD at functional MR imaging. References…
Douglas P. Slakey, MD, MPH, Regents Professor and Chair, Department of Surgery, Tulane University School of Medicine, discusses optimizing transplant patient outcomes. References and Resources American Liver Foundation…
